IRF9

protein-coding

interferon regulatory factor 9, the group of Interferon regulatory factors

Gene summary

This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Mutations in this gene result in Immunodeficiency 65. [provided by RefSeq, Jul 2020]

Previous symbols:
  • ISGF3G

MANE transcript

NM_006084.5

Inheritance

AR

ClinVar variants

U:132B:75

Top phenotype

Immunodeficiency 65

gnomAD constraint

pLI —, LoF o/e 0.2

Max pathogenic AF

—

Genomic locus

chr14:24,161,234-24,168,043

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~6.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

immunodeficiency 65, susceptibility to viral infectionsMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0032848

Submitter: PanelApp Australia

immunodeficiency 65, susceptibility to viral infectionsMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0032848

Submitter: ClinGen

*IRF9* was first reported in relation to Autosomal Recessive susceptibility to viral infection in 2018 (PMID:30143481). At least 2 unique variants (missense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Experimental evidence incldues evidence of functional alteration (PMID 35182547, 30143481 and 30826365), rescue model (PMID 30143481 and 30826365), cell culture model (PMID 30826365), and mouse model (PMID 22496215). Variants in this gene have been reported in at least 2 probands in 2 publications (PMID 30143481 and 30826365). Variants in this gene segregated with disease in 1 additional family member. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged.

immunodeficiency 65, susceptibility to viral infectionsLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0032848

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Immunodeficiency 65AR

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: Individuals have been described with early-onset severe and recurrent viral infections, and antiinfectious prophylaxis (intravenous immunoglobulin has been described) and early and aggressive treatment of infections may be beneficial; live attenuated vaccines have been reported as resulting in poor outcomes in patients with impaired interferon responses

Refs: 30143481; 30826365Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to IRF9 variants in ClinVar

4 Conditions Cataloged
not providedTotal: 240
not specifiedTotal: 54
Immunodeficiency 65, susceptibility to viral infectionsTotal: 5
IRF9-related disorderTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006084.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
64
clinvar
2
clinvar
67
missense
123
clinvar
9
clinvar
132
nonsense
1
clinvar
1
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
3
clinvar
3
Total00132732207
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 96 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006084.5RefSeqNP_006075.38MANE Select
ENST00000396864.8EnsemblENSP00000380073.38MANE Select
NM_001385400.1RefSeqNP_001372329.19Standard
NM_001385401.1RefSeqNP_001372330.18Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human)
  • Jak-STAT signaling pathway - Homo sapiens (human)
  • Influenza A - Homo sapiens (human)
  • Necroptosis - Homo sapiens (human)
  • NOD-like receptor signaling pathway - Homo sapiens (human)

Biological Process

  • regulation of transcription by RNA polymerase II
  • transcription by RNA polymerase II
  • cell surface receptor signaling pathway
  • defense response to virus
  • interferon-gamma-mediated signaling pathway

Molecular Function

  • RNA polymerase II proximal promoter sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription factor activity
  • protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000396864
Coding exons
8
Length
5513
Individuals with no LoFs
125738
Homozygous LoFs
0
Heterozygous LoFs
6
Defined
125744
p
0.0000239
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.571612280.7070.00001282551
Missense (PolyPhen)4893.6050.512791036
Synonymous1.267388.00.8300.00000483778
Loss of Function3.36420.40.1960.00000113204

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.0000610.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000450.000044rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcription factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.;

Intolerance Scores

LoFtool
0.147
RVIS EVS
-0.16
RVIS percentile EVS
41.91

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.861

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.